A Novel Scoring System for Patients with Recurrence of Hepatocellular Carcinoma After Undergoing Minimal Invasive Therapies.
Qi WangLiang MaJianjun LiChunwang YuanJianping SunKang LiLing QinChaoran ZangYanan ZhaoYan ZhaoYonghong ZhangPublished in: Cancer management and research (2019)
The scoring system of the present study for patients with the recurrence of HCC after undergoing TACE combined with local ablation may help physicians make a reasonable clinical decision, providing ideal management for diagnosis and treatment.